Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid
Titel:
Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid
Auteur:
Kander, Elizabeth M. Shah, Manisha H. Zhou, Ye Goyal, Ashima Palmer, Joshua D. Owen, Dwight H. Shilo, Konstantin Patel, Gopal Raval, Raju R. Gonzalez, Javier Nguyen, Michele Olek, Elizabeth Kherani, Jennifer Rothenberg, S. Michael Konda, Bhavana